PNC Financial Services Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-11
| Closed | – | – | 4150 |
|
|
2019
Q3 | $0 | Hold |
11
| – | – | ﹤0.01% | 4150 |
|
|
2019
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 4181 |
|
|
2017
Q4 | – | Sell |
-245,337
| Closed | -$3.62M | – | 4279 |
|
|
2017
Q3 | $3.62M | Buy |
245,337
+197,565
| +414% | +$2.91M | ﹤0.01% | 823 |
|
|
2017
Q2 | $667K | Buy |
+47,772
| New | +$667K | ﹤0.01% | 1467 |
|
|
2016
Q3 | – | Sell |
-51,109
| Closed | -$574K | – | 4354 |
|
|
2016
Q2 | $574K | Buy |
51,109
+708
| +1% | +$7.95K | ﹤0.01% | 1486 |
|
|
2016
Q1 | $689K | Buy |
50,401
+24,548
| +95% | +$336K | ﹤0.01% | 1414 |
|
|
2015
Q4 | $491K | Buy |
+25,853
| New | +$491K | ﹤0.01% | 1547 |
|
|
2015
Q3 | – | Sell |
-2,000
| Closed | -$30K | – | 4730 |
|
|
2015
Q2 | $30K | Hold |
2,000
| – | – | ﹤0.01% | 3313 |
|
|
2015
Q1 | $30K | Buy |
+2,000
| New | +$30K | ﹤0.01% | 3313 |
|